Adherium Ltd has released a press release.
New CEO Appointed - Dr Paul Mastoridis
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Adherium
- Resignation of CEO
- Notice of Annual General Meeting/Proxy Form
- Annual Report to shareholders
- Adherium SPP and Shortfall Offers Prospectus
- Adherium secures $13.5m in placement commitments
Later from Adherium
- Adherium receives $1.5m Australian R&D Tax Rebate
- First Patient Enrolled in Major e-health Clinical Study
- Placement and Entitlement Offer to raise up to $8.37 million
- Non-Renounceable Rights Issue Offer Completes
- AstraZeneca selected Adherium Smartinhaler for its study
Follow Adherium into a list and get an email when it puts out news.
Follow Adherium